Overall survival data from LUX-Lung 7 head-to-head trial of afatinib ve
A reduction in the risk of death was observed in the LUX-Lung 7 trial for pa...
2016-10-11
文传商讯
New analysis showed dose adjustment of Giotrif (afatinib) improved tole
A new analysis from two Phase III trials published in Annals of Oncology sho...
2016-09-09
文传商讯
Giotrif (afatinib) approved in Europe as new oral treatment option for
Approval provides a new oral treatment option for patients with the second l...
2016-04-08
文传商讯
